Silymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetes (Q46987748)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2007
edit
Language Label Description Also known as
English
Silymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetes
scientific article published in September 2007

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit